January/February 2023

Column

Trending From ACCC

Improving the Care of Patients With Advanced Nonmelanoma Skin Cancers

02/06/2023

Association of Community Cancer Centers

In 2022, the Association of Community Cancer Centers (ACCC) developed the Advanced Non-Melanoma Skin Cancers Visiting Experts Program to educate multidisciplinary providers through interactive, virtual discussions on effective practices for...

In 2022, the Association of...

02/06/2023

Journal of Clinical Pathways

Editor's Page

The Next 5 Years for Medication Spending

02/06/2023

Winston Wong, PharmD, Editor-in-Chief

Editor-in-Chief, Winston Wong, PharmD, outlines the Global Use of Medicines 2023 report on the next 5 years of medical spending and how the health care industry must continue to improve efficiency and quality, informed by evidence-based...

Editor-in-Chief, Winston Wong,...

02/06/2023

Journal of Clinical Pathways

Feature Interview

Supporting the Employee Journey Through Cancer: Carrum Health and AccessHope’s Partnership

02/06/2023

The Cancer Care Business Exchange is a high-level, multistakeholder forum focusing on the business implications of the changing complexities in cancer care delivery and payment through conversations between those who have interest, influence,...

The Cancer Care Business...

02/06/2023

Journal of Clinical Pathways

Feature

Research Reports

Belief in Research, Religious Coping, and Willingness to Participate in Clinical Trials Among African American Patients With Hematologic Malignancies: A Pilot Study

02/06/2023

Marjorie E Petty, PhD, MSN

Cynthia Chernecky, PhD, RN, AOCN, FAAN

Irina Shishkina, BSN

Nita Maihle, PhD

Jean Pawl, PhD, RN, OCN, CNE

Jennifer L Waller, PhD

Lufei Young, PhD, RN, APRN-NP

Julie Zadinsky, PhD, MSS, RN, CIP

Petty et al evaluated the belief in research, religious coping, and willingness to participate in clinical trials by African American patients with hematologic malignancies. The basis for their exploration is that, while the AA population has...

Petty et al evaluated the belief...

02/06/2023

Journal of Clinical Pathways

Research Reports

Post–COVID-19 Syndrome Clinical Pathway for the US Veterans Health Administration

02/06/2023

Claudia L Campos, MD

Cristina Nguyen, BS

Kristina Crothers, MD

Omar Awan, MD

Francis J Miller Jr, MD

Courtney Sedillo, MSN, FNP-C

Johnson Vachachira, NP

Carrie B May, PsyD

Allison M Gustavson, DPT, PhD

Jacob B Lindheimer, PhD

Lindheimer et al summarize the stepwise diagnostic approach for patients presenting with PCS dyspnea and/or cough in primary care and highlight teleconsultation and telerehabilitation as opportunities to reach those in rural areas or with...

Lindheimer et al summarize the...

02/06/2023

Journal of Clinical Pathways

Insights

NGS Institute

The NGS Institute: Advancing the Appropriate Use of Biomarker Testing

02/06/2023

Gordon Kuntz

The NGS Institute is a trusted resource for curated, practical information on biomarker and next-generation sequencing testing. This article outlines the aim the Institute has to play a role in facilitating the integration of genomic-level...

The NGS Institute is a trusted...

02/06/2023

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

January/February 2023

Column

Feature

Insights

Current Issue

Special Reports

Subscribe

February 2023 Volume 9 Issue 1

Specialties

Events

Year Round Education

HMP Global Products